Retreatment with carboplatin and paclitaxel for recurrent endometrial cancer: A retrospective study of the Memorial Sloan Kettering Cancer Center experience

Women with endometrial cancer (EC) frequently receive adjuvant paclitaxel and carboplatin (PC) chemotherapy. There is no standard first line chemotherapy at disease recurrence. Data extrapolated from ovarian cancer has suggested that patients with recurrent EC may benefit from further platinum-based...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Gynecol Oncol Rep
Hoofdauteurs: Rubinstein, Maria, Halpenny, Darragh, Makker, Vicky, Grisham, Rachel N., Aghajanian, Carol, Cadoo, Karen
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Elsevier 2019
Onderwerpen:
Case Series
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6461565/
https://ncbi.nlm.nih.gov/pubmed/31011610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gore.2019.04.002
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items